Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
IL-1β–driven osteoclastogenic Tregs accelerate bone erosion in arthritis
Anaïs Levescot, … , Julia F. Charles, Peter A. Nigrovic
Anaïs Levescot, … , Julia F. Charles, Peter A. Nigrovic
Published August 3, 2021
Citation Information: J Clin Invest. 2021;131(18):e141008. https://doi.org/10.1172/JCI141008.
View: Text | PDF
Research Article Autoimmunity Inflammation

IL-1β–driven osteoclastogenic Tregs accelerate bone erosion in arthritis

  • Text
  • PDF
Abstract

IL-1β is a proinflammatory mediator with roles in innate and adaptive immunity. Here we show that IL-1β contributes to autoimmune arthritis by inducing osteoclastogenic capacity in Tregs. Using mice with joint inflammation arising through deficiency of the IL-1 receptor antagonist (Il1rn–/–), we observed that IL-1β blockade attenuated disease more effectively in early arthritis than in established arthritis, especially with respect to bone erosion. Protection was accompanied by a reduction in synovial CD4+Foxp3+ Tregs that displayed preserved suppressive capacity and aerobic metabolism but aberrant expression of RANKL and a striking capacity to drive RANKL-dependent osteoclast differentiation. Both Il1rn–/– Tregs and wild-type Tregs differentiated with IL-1β accelerated bone erosion upon adoptive transfer. Human Tregs exhibited analogous differentiation, and corresponding RANKLhiFoxp3+ T cells could be identified in rheumatoid arthritis synovial tissue. Together, these findings identify IL-1β–induced osteoclastogenic Tregs as a contributor to bone erosion in arthritis.

Authors

Anaïs Levescot, Margaret H. Chang, Julia Schnell, Nathan Nelson-Maney, Jing Yan, Marta Martínez-Bonet, Ricardo Grieshaber-Bouyer, Pui Y. Lee, Kevin Wei, Rachel B. Blaustein, Allyn Morris, Alexandra Wactor, Yoichiro Iwakura, James A. Lederer, Deepak A. Rao, Julia F. Charles, Peter A. Nigrovic

×

Figure 5

IL-1β confers osteoclastogenic potential to Tregs.

Options: View larger image (or click on image) Download as PowerPoint
IL-1β confers osteoclastogenic potential to Tregs.
CD4+ naive cells from...
CD4+ naive cells from WT mice were isolated and cultured in Treg differentiation media with or without IL-1β (n = 6 per group). (A–C) Foxp3eGFP expression by flow cytometry after 5 days of Treg differentiation with or without IL-1β (D and E). iTregs were sorted based on Foxp3eGFP expression and cocultured with bone marrow cells in the presence of M-CSF (20 ng/mL) and RANKL (20 ng/mL) (n = 3 per group). (D and E) High-dimensional analyses of sorted Foxp3eGFP+ iTregs differentiated with or without IL-1β by mass cytometry. (D) viSNE plots of iTregs differentiated with or without IL-1β. (E) Difference in protein expression between iTregs differentiated with or without IL-1β. (F–H) Sorted Foxp3eGFP+ iTreg cells differentiated with or without IL-1β were cocultured with WT macrophage precursor cells. After 7 days of coculture, cells were stained for tartrate-resistant acid phosphatase (TRAP) and TRAP+ osteoclasts were measured (surface area) and counted. Scale bars: 1 mm. (I and J) RANKL-deficient Tregs were generated by crossing FoxP3-YFP-Cre mice with Ranklfl/fl mice. Littermate mice that do not express FoxP3-YFP-Cre were utilized as WT controls. (I) Histogram depicting RANKL expression on WT and Rankl–/– Tregs. (J) Osteoclastogenic activity of WT and Rankl–/– Tregs differentiated in the presence or absence of IL-1β. Data are expressed as mean ± SEM. Statistical significance was determined using Mann-Whitney U test (B and C), unpaired t test (F), or 1-way ANOVA (G–I). *P < 0.01, **P < 0.001, ***P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts